The UK electroceuticals market is expected to grow at a CAGR of 7.5% during the forecast period. UK has the highest number of cardiovascular diseases, coronary heart disease, stroke, heart failure, atrial fibrillation, and other heart patients in Europe. Prolonged diseases, such as arthritis, asthma, chronic obstructive pulmonary disease, diabetes, and other heart-related diseases put economic burden on the UK government, which includes cost of premature fatalities, hospital stay, and prescriptions, and these are estimated to be approximately $50 billion annually.
The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By end-user segment, the market is segmented into hospitals & clinics and homecare and other.
Few players operating in the UK electroceuticals market include Medtronic PLC, Abbott Laboratories Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp. These players adopt various strategies in order to remain competitive in the global market. For instance, in September 2017, the company in partnership with MicroPort announced the approval of the Rega Pacemaker from the China Food and Drug Administration. This device offers various advanced features, such as pacing mode that preserves intrinsic conduction, a dual sensor-based response rate to sleep and exercise monitoring.
Research Methodology
The market study of the UK electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK Electroceuticals Market by Product and its Application
5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker
5.1.1.1. Arrhythmias
5.1.2. Deep Brain Stimulators
5.1.2.1. Parkinson’s Disease
5.1.2.2. Depression
5.1.3. Spinal Cord Stimulators
5.1.3.1. Failed Back Syndrome
5.1.3.2. Ischemia
5.1.4. Vagus Nerve Stimulators
5.1.4.1. Epilepsy
5.1.5. Cochlear Implants
5.1.5.1. Sensorineural Hearing Loss
5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
5.1.6.1. Urinary Incontinence
5.1.6.2. Treatment-Resistant Depression
5.2. UK Electroceuticals Market by End-User
5.2.1. Hospitals and Clinics
5.2.2. Homecare and Other
6. Company Profiles
6.1. Abbott Laboratories Inc.
6.2. Advanced Bionics AG
6.3. Boston Scientific Corp.
6.4. Demant A/S
6.5. Edwards Lifesciences Corp.
6.6. Getinge AB
6.7. GlaxoSmithKline PLC
6.8. Livanova PLC
6.9. Medtronic PLC
6.10. Renishaw PLC
6.11. Sonova Holding AG
1. UK ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
2. UK ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. UK ELECTROCEUTICALS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
2. UK ELECTROCEUTICALS MARKET SHARE BY END-USER, 2018 VS 2025 (%)